Oculis Holding AG ( OCS) - Key Metrics
OCS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.42 | -$0.29 | -$0.29 |
| 2025Q3 | $0 | -$0.32 | -$0.25 | -$0.26 |
| 2025Q2 | $0 | -$0.49 | -$0.33 | -$0.33 |
| 2025Q1 | ? | -$0.69 | -$0.39 | -$0.42 |
OCS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -9.50 |
| 2025Q3 | ? | -10.92 |
| 2025Q2 | ? | -7.93 |
| 2025Q1 | ? | -6.11 |
OCS
Price: $11.09
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Market Capitalization: 735.8 million